We serve Chemical Name:1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one CAS:30818-17-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one
CAS.NO:30818-17-8
Synonyms:MFCD00142557;EINECS 250-347-9
Molecular Formula:C13H14N4O3
Molecular Weight:274.27500
HS Code:2933990090
Physical and Chemical Properties:
Melting point:205-208 °C(lit.)
Boiling point:444.4ºC at 760 mmHg
Density:1.47g/cm3
Index of Refraction:1.708
PSA:81.73000
Exact Mass:274.10700
LogP:1.70250
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like MFCD00142557 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 250-347-9 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 250-347-9 Use and application,MFCD00142557 technical grade,usp/ep/jp grade.
Related News: The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. 1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one manufacturer Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one supplier In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances. 1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one vendor In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one factory With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.
